1 terminated, 1 unknown. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 1, Unknown 1 |
| Phase 2 | 2 | Terminated 1, Unknown 1 |
Follow SC: new trials by email Literature Review of SC trials Research Report on SC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Inhaled Interferon α2b Treatment in Mild-to-moderate COVID-19 Infected Children Inhaled Interferon α2b, Standard of Care - COVID-19, Children | Phase 1 / Phase 2 | Terminated | Children's Hospital of Fudan University | 24 | 2022-01-01 | 2023-12-29 |
| Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus GLP-1, SC, Standard Medical Treatment - Type 2 Diabetes | Phase 1 / Phase 2 | Unknown | Diabetes Care Center of Nanjing Military Command | 100 | 2013-10-01 | 2014-02-20 |
COVID-19 (1) · Diabetes Mellitus, Type 2 (1)
Children's Hospital of Fudan University (1) · Diabetes Care Center of Nanjing Military Command (1)
China (2)